Literature DB >> 3717562

Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent.

M S Bernatowicz, G R Matsueda.   

Abstract

Synthetic peptides derived from human fibrin were unidirectionally conjugated to three carrier proteins (bovine serum albumin, bovine alpha-lactalbumin, and keyhole limpet hemocyanin) by a method that employs N-succinimidyl bromoacetate. This heterobifunctional crosslinking reagent was prepared with a 79% yield in gram quantities from inexpensive starting materials. With this reagent, carrier proteins were first bromoacetylated, then reacted with the thiol groups of cysteine-containing peptides. The extent of peptide conjugation was assessed by amino acid analysis after acid hydrolysis, which liberated 1 mol of S-carboxymethylcysteine for each mole of thioether linkage between peptide and protein. The results of several conjugation experiments indicated that the efficiency of peptide incorporation ranged between 22 and 37% based on the recovery of S-carboxymethylcysteine relative to lysine. When the conjugates were used as immunogens, the S-carboxymethyl linkage was not antigenic in comparison with the S-maleimidobenzoyl linkage, even though their antipeptide immunoreactivities were similar.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3717562     DOI: 10.1016/0003-2697(86)90231-9

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  30 in total

Review 1.  The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways.

Authors:  J S Mort; D J Buttle
Journal:  Mol Pathol       Date:  1999-02

2.  Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates.

Authors:  Vishwesh Patil; Keyur Gada; Rajiv Panwar; Alexandra Varvarigou; Stan Majewski; Andrew Weisenberger; Craig Ferris; Yared Tekabe; Ban-An Khaw
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05       Impact factor: 9.236

Review 3.  Recent advances in the molecular design of synthetic vaccines.

Authors:  Lyn H Jones
Journal:  Nat Chem       Date:  2015-12       Impact factor: 24.427

4.  Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates.

Authors:  A F Verheul; G J Boons; G A Van der Marel; J H Van Boom; H J Jennings; H Snippe; J Verhoef; P Hoogerhout; J T Poolman
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

5.  Generation and purification of highly specific antibodies for detecting post-translationally modified proteins in vivo.

Authors:  Swathi Arur; Tim Schedl
Journal:  Nat Protoc       Date:  2014-01-23       Impact factor: 13.491

6.  Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus.

Authors:  T D Brumeanu; S Casares; A Bot; S Bot; C A Bona
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Design and synthesis of polyacrylamide-based oligonucleotide supports for use in nucleic acid diagnostics.

Authors:  E Fahy; G R Davis; L J DiMichele; S S Ghosh
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

8.  Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.

Authors:  E Alonso de Velasco; A F Verheul; A M van Steijn; H A Dekker; R G Feldman; I M Fernández; J P Kamerling; J F Vliegenthart; J Verhoef; H Snippe
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

9.  Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.

Authors:  A F Verheul; A K Braat; J M Leenhouts; P Hoogerhout; J T Poolman; H Snippe; J Verhoef
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself.

Authors:  L Mach; H Schwihla; K Stüwe; A D Rowan; J S Mort; J Glössl
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.